Search

Search Constraints

You searched for: Author/Creator Marek, Kenneth

Search Results

11. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study. Issue 5 (19th February 2020)

12. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Issue 1 (January 2020)

13. Clinical and Imaging Progression in the PARS Cohort: Long‐Term Follow‐up. Issue 9 (13th July 2020)

14. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective. (4th March 2017)

16. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings. Issue 1 (21st August 2015)

18. Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs. Issue 3 (5th December 2019)

19. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Issue 14 (11th August 2015)

20. Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder. Issue 1 (15th December 2020)